SMTL ID : 2uzo.1

Crystal structure of human CDK2 complexed with a thiazolidinone inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x C62: 4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE(Non-covalent)

C62.1: 14 residues within 4Å: Chain A: I.10, A.31, K.33, F.80, E.81, F.82, L.83, H.84, Q.85, D.86, K.89, N.132, L.134, D.145 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.10, A:F.82, A:D.86, A:L.134, A:L.134 Hydrogen bonds: A:K.33, A:K.33, A:D.86, A:N.132 Water bridges: A:D.145

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Richardson, C.M. et al., Discovery of a Potent Cdk2 Inhibitor with a Novel Binding Mode, Using Virtual Screening and Initial, Structure-Guided Lead Scoping. Bioorg.Med.Chem.Lett. (2007)

Release Date

2007-06-26

Peptides

CELL DIVISION PROTEIN KINASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CELL DIVISION PROTEIN KINASE 2

Related Entries With Identical Sequence